These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36761972)

  • 21. Single-Cell RNA Sequencing Reveals Tissue Compartment-Specific Plasticity of Mycosis Fungoides Tumor Cells.
    Rindler K; Bauer WM; Jonak C; Wielscher M; Shaw LE; Rojahn TB; Thaler FM; Porkert S; Simonitsch-Klupp I; Weninger W; Mayerhoefer ME; Farlik M; Brunner PM
    Front Immunol; 2021; 12():666935. PubMed ID: 33968070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts.
    Lee CS; Ungewickell A; Bhaduri A; Qu K; Webster DE; Armstrong R; Weng WK; Aros CJ; Mah A; Chen RO; Lin M; Sundram U; Chang HY; Kretz M; Kim YH; Khavari PA
    Blood; 2012 Oct; 120(16):3288-97. PubMed ID: 22936659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of T Lymphoma Cells and Immunological Invigoration in a Patient Concurrently Affected by Melanoma and Sezary Syndrome Treated With Nivolumab.
    Narducci MG; Tosi A; Frezzolini A; Scala E; Passarelli F; Bonmassar L; Monopoli A; Accetturi MP; Cantonetti M; Antonini Cappellini GC; De Galitiis F; Rosato A; Picozza M; Russo G; D'Atri S
    Front Immunol; 2020; 11():579894. PubMed ID: 33072126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Th1 response and cytotoxicity genes are down-regulated in cutaneous T-cell lymphoma.
    Hahtola S; Tuomela S; Elo L; Häkkinen T; Karenko L; Nedoszytko B; Heikkilä H; Saarialho-Kere U; Roszkiewicz J; Aittokallio T; Lahesmaa R; Ranki A
    Clin Cancer Res; 2006 Aug; 12(16):4812-21. PubMed ID: 16914566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naïve/memory T-cell phenotypes in leukemic cutaneous T-cell lymphoma: Putative cell of origin overlaps disease classification.
    Horna P; Moscinski LC; Sokol L; Shao H
    Cytometry B Clin Cytom; 2019 May; 96(3):234-241. PubMed ID: 30328260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Localization of clonal T cells to the epidermis in cutaneous T-cell lymphoma.
    Fivenson DP; Hanson CA; Nickoloff BJ
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):717-23. PubMed ID: 7929915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses.
    Harmon CB; Witzig TE; Katzmann JA; Pittelkow MR
    J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):404-10. PubMed ID: 8784277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved Sézary cell detection and novel insights into immunophenotypic and molecular heterogeneity in Sézary syndrome.
    Najidh S; Tensen CP; van der Sluijs-Gelling AJ; Teodosio C; Cats D; Mei H; Kuipers TB; Out-Luijting JJ; Zoutman WH; van Hall T; Orfao A; Almeida J; van Dongen JJM; Vermeer MH
    Blood; 2021 Dec; 138(24):2539-2554. PubMed ID: 34314480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-cell analyses reveal novel molecular signatures and pathogenesis in cutaneous T cell lymphoma.
    Xue X; Wang Z; Mi Z; Liu T; Wang C; Shi P; Sun L; Yang Y; Li W; Wang Z; Liu H; Zhang F
    Cell Death Dis; 2022 Nov; 13(11):970. PubMed ID: 36400759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-cell heterogeneity in Sézary syndrome.
    Buus TB; Willerslev-Olsen A; Fredholm S; Blümel E; Nastasi C; Gluud M; Hu T; Lindahl LM; Iversen L; Fogh H; Gniadecki R; Litvinov IV; Persson JL; Bonefeld CM; Geisler C; Christensen JP; Krejsgaard T; Litman T; Woetmann A; Ødum N
    Blood Adv; 2018 Aug; 2(16):2115-2126. PubMed ID: 30139925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-Cell Heterogeneity of Cutaneous T-Cell Lymphomas Revealed Using RNA-Seq Technologies.
    Rassek K; Iżykowska K
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous histopathology of Sézary syndrome: a study of 41 cases with a proven circulating T-cell clone.
    Trotter MJ; Whittaker SJ; Orchard GE; Smith NP
    J Cutan Pathol; 1997 May; 24(5):286-91. PubMed ID: 9194581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of cell surface molecules characterizing human cutaneous T-cell lymphomas.
    Nikolova M; Bagot M; Boumsell L; Bensussan A
    Leuk Lymphoma; 2002 Apr; 43(4):741-6. PubMed ID: 12153159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sézary syndrome without erythroderma: A review of 16 cases at Mayo Clinic.
    Thompson AK; Killian JM; Weaver AL; Pittelkow MR; Davis MD
    J Am Acad Dermatol; 2017 Apr; 76(4):683-688. PubMed ID: 28012574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic and prognostic importance of T-cell receptor gene analysis in patients with Sézary syndrome.
    Fraser-Andrews EA; Russell-Jones R; Woolford AJ; Wolstencroft RA; Dean AJ; Whittaker SJ
    Cancer; 2001 Oct; 92(7):1745-52. PubMed ID: 11745245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined High-Throughput Approaches Reveal the Signals Driven by Skin and Blood Environments and Define the Tumor Heterogeneity in Sézary Syndrome.
    Cristofoletti C; Bresin A; Fioretti M; Russo G; Narducci MG
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New perspectives in experimental and clinical research for cutaneous T cell lymphomas.
    Burg G; Häffner A; Böni R; Dommann S; Dummer R
    Recent Results Cancer Res; 1995; 139():225-37. PubMed ID: 7597294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sézary Syndrome, recent biomarkers and new drugs.
    Cristofoletti C; Narducci MG; Russo G
    Chin Clin Oncol; 2019 Feb; 8(1):2. PubMed ID: 30525758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
    Klemke CD; Fritzsching B; Franz B; Kleinmann EV; Oberle N; Poenitz N; Sykora J; Banham AH; Roncador G; Kuhn A; Goerdt S; Krammer PH; Suri-Payer E
    Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of the Voltage-Gated Potassium Channel Kv1.3 in Lesional Skin from Patients with Cutaneous T-Cell Lymphoma and Benign Dermatitis.
    Hu T; Krejsgaard T; Nastasi C; Buus TB; Nansen A; Hald A; Spee P; Nielsen PR; Blümel E; Gluud M; Willerslev-Olsen A; Woetmann A; Bzorek M; Eriksen JO; Ødum N; Rahbek Gjerdrum LM
    Dermatology; 2020; 236(2):123-132. PubMed ID: 31536992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.